Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial

Jerzy R Kowalczyk; Joanna Zawitkowska; Monika Lejman; Katarzyna Drabko; Marzena Samardakiewicz; Michał Matysiak; Michał Romiszewski; Walentyna Balwierz; Magdalena Ćwiklińska; Bernarda Kazanowska; Joanna Owoc-Lempach; Jacek Wachowiak; Katarzyna Derwich; Elżbieta Adamkiewicz-Drożyńska; Maciej Niedźwiecki; Joanna Trelińska; Wojciech Młynarski; Mariusz Wysocki; Andrzej Kołtan; Tomasz Szczepański; Maryna Krawczuk-Rybak; Anna Kitszel; Maria Wieczorek; Tomasz Urasiński; Tomasz Ociepa; Grażyna Sobol-Milejska; Agnieszka Mizia-Malarz; Grażyna Karolczyk; Jan Stary

doi:10.1002/ajh.25619

Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial

Am J Hematol. 2019 Nov;94(11):E307-E310. doi: 10.1002/ajh.25619. Epub 2019 Aug 30.

Authors

Jerzy R Kowalczyk¹, Joanna Zawitkowska¹, Monika Lejman², Katarzyna Drabko¹, Marzena Samardakiewicz^{1

3}, Michał Matysiak⁴, Michał Romiszewski⁴, Walentyna Balwierz⁵, Magdalena Ćwiklińska⁵, Bernarda Kazanowska⁶, Joanna Owoc-Lempach⁶, Jacek Wachowiak⁷, Katarzyna Derwich⁷, Elżbieta Adamkiewicz-Drożyńska⁸, Maciej Niedźwiecki⁸, Joanna Trelińska⁹, Wojciech Młynarski⁹, Mariusz Wysocki¹⁰, Andrzej Kołtan¹⁰, Tomasz Szczepański¹¹, Maryna Krawczuk-Rybak¹², Anna Kitszel¹², Maria Wieczorek¹³, Tomasz Urasiński¹³, Tomasz Ociepa¹³, Grażyna Sobol-Milejska¹⁴, Agnieszka Mizia-Malarz¹⁴, Grażyna Karolczyk¹⁵, Jan Stary¹⁶

Affiliations

¹ Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland.
² Department of Pediatric Hematology, Oncology and Transplantology, Laboratory of Genetic Diagnostics, Medical University of Lublin, Lublin, Poland.
³ Department of Applied Psychology, Medical University of Lublin, Lublin, Poland.
⁴ Department of Hematology and Pediatrics, Children's Hospital, Warsaw, Poland.
⁵ Department of Pediatric Oncology and Hematology, Children's University Hospital, Jagiellonian University, Kraków, Poland.
⁶ Department of Pediatric Transplantology, Oncology, Hematology, Medical University of Wrocław, Wrocław, Poland.
⁷ Department of Pediatric Oncology, Hematology and Transplantology, Medical University of Poznań, Poznań, Poland.
⁸ Department of Pediatrics, Hematology, Oncology and Endocrinology, Medical University of Gdańsk, Gdańsk, Poland.
⁹ Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Łódź, Łódź, Poland.
¹⁰ Department of Pediatrics, Hematology and Oncology, Collegium Medicum of Bydgoszcz, Bydgoszcz, Poland.
¹¹ Department of Pediatrics, Hematology and Oncology, Medical University of Zabrze, Zabrze, Poland.
¹² Department of Pediatric Oncology, Hematology, Medical University of Białystok, Białystok, Poland.
¹³ Department of Pediatrics, Hematology and Oncology, Medical University of Szczecin, Szczecin, Poland.
¹⁴ Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Katowice, Katowice, Poland.
¹⁵ Department of Pediatric Oncology and Hematology, Children's Hospital, Kielce, Poland.
¹⁶ Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.

No abstract available

Publication types

Clinical Trial
Letter
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cause of Death
Cell Lineage
Child
Child, Preschool
Chromosome Aberrations
Female
Humans
Immunophenotyping
Infant
Kaplan-Meier Estimate
Male
Poland / epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
Prednisone / administration & dosage
Recurrence
Risk Factors
Treatment Outcome

Substances

Prednisone

Grants and funding

STRATEGMED3/304586/5/NCBR/2017/National Centre for Research and Development, Poland/International